International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels, Belgium: International Diabetes Federation; 2021.

Google Scholar 

Azadnajafabad S, Ahmadi N, Rezaei N, Rashidi M-M, Saeedi Moghaddam S, Mohammadi E, et al. Evaluation of the diabetes care cascade and compliance with WHO global coverage targets in Iran based on STEPS survey 2021. Sci Rep. 2023;13(1):13528.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Acs A, Ludwig C, Bereza BG, Einarson TR, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: A global systematic review. Value Health. 2017;20(9):A475.

Article  Google Scholar 

Low Wang CC, Hess CN, Hiatt WR, Goldfine AB. Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes Mellitus - mechanisms, management, and clinical considerations. Circulation. 2016;133(24):2459–502.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Newman JD, Schwartzbard AZ, Weintraub HS, Goldberg IJ, Berger JS. Primary Prevention of cardiovascular disease in diabetes mellitus. J Am Coll Cardiol. 2017;70(7):883–93.

Article  PubMed  PubMed Central  Google Scholar 

Einarson TR, Acs A, Ludwig C, Panton UH. Economic burden of cardiovascular disease in Type 2 diabetes: a systematic review. Value in Health. 2018;21(7):881–90.

Article  PubMed  Google Scholar 

Chamberlain AM, Cohen SS, Killian JM, Monda KL, Weston SA, Okerson T. Lipid-lowering prescription patterns in patients with diabetes mellitus or cardiovascular disease. Am J Cardiol. 2019;124(7):995–1001.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dhanaraj E, Raval A, Yadav R, Bhansali A, Tiwari P. Prescription pattern of Antihypertensive Agents in T2DM patients visiting Tertiary Care Centre in North India. Int J Hypertens. 2012;2012:520915.

Article  PubMed  PubMed Central  Google Scholar 

Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–22.

Article  Google Scholar 

WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment, 2023. Oslo; 2022.

American Diabetes Association Professional Practice C. 10. Cardiovascular disease and risk management: standards of medical care in diabetes—2022. Diabetes Care. 2021;45(Supplement1):144–S174.

Google Scholar 

Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ et al. 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes: Developed by the task force on the management of cardiovascular disease in patients with diabetes of the european society of cardiology (ESC). Eur Heart J. 2023. [Epub ahead of print]

Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC). Eur Heart J. 2021;42(34):3227–337.

Article  PubMed  Google Scholar 

Pharmaceutical statistical database 2016. FDA. https://Fda.gov.ir/. Accessed 12 Oct 2020.

World Health Organization. Noncommunicable D. Mental Health Cluster. Surveillance T. STEPS instruments for NCD risk factors (core and expanded version 1.4): the WHO STEPwise approach to Surveillance of noncommunicable diseases (STEPS). Geneva: World Health Organization; 2001.

Djalalinia S, Modirian M, Sheidaei A, Yoosefi M, Zokaiee H, Damirchilu B, et al. Protocol design for large–scale cross–sectional studies of surveillance of risk factors of non–communicable diseases in Iran: STEPs 2016. Arch Iran Med. 2017;20(9).

Veeramani V, Muraleedharan A. Study on drug utilization pattern in cardiology outpatient department at tertiary care hospitals in South India: a prospective multicenter cross-sectional observational study. 2020.

Naliganti C, Valupadas C, Akkinepally RR, Eesam S. Evaluation of drug utilization in cardiovascular disease at a teaching and referral hospital in Northern Telangana. Indian J Pharmacol. 2019;51(5):323–9.

Article  PubMed  PubMed Central  Google Scholar 

Tsujimoto T, Sugiyama T, Shapiro MF, Noda M, Kajio H. Risk of cardiovascular events in patients with diabetes mellitus on β-blockers. Hypertension. 2017;70(1):103–10.

Article  CAS  PubMed  Google Scholar 

Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus. N Engl J Med. 2018;379(16):1529–39.

Article  Google Scholar 

Haffner SM, Alexander CM, Cook TJ, Boccuzzi SJ, Musliner TA, Pedersen TR, et al. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the scandinavian simvastatin survival study. Arch Intern Med. 1999;159(22):2661–7.

Article  CAS  PubMed  Google Scholar 

Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil W, Livingstone HA. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the collaborative atorvastatin diabetes study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364(9435):685–96.

Article  CAS  PubMed  Google Scholar 

Cheng J, Zhang W, Zhang X, Han F, Li X, He X, et al. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause Mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a Meta-analysis. JAMA Intern Med. 2014;174(5):773–85.

Article  CAS  PubMed  Google Scholar 

Kasiske BL, Kalil RS, Ma JZ, Liao M, Keane WF. Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis. Ann Intern Med. 1993;118(2):129–38.

Article  CAS  PubMed  Google Scholar 

Parving H-H, Hommel E, Jensen BR, Hansen HP. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients. Kidney Int. 2001;60(1):228–34.

Article  CAS  PubMed  Google Scholar 

Brenner BM, Cooper ME, De Zeeuw D, Keane WF, Mitch WE, Parving H-H, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345(12):861–9.

Article  CAS  PubMed  Google Scholar 

Chan You S, Krumholz HM, Suchard MA, Schuemie MJ, Hripcsak G, Chen R, et al. Comprehensive comparative effectiveness and safety of first-line β-blocker monotherapy in hypertensive patients: a large-scale multicenter observational study. Hypertension (Dallas, Tex: 1979). 2021;77(5):1528–38.

Article  CAS  PubMed  Google Scholar 

Rodriguez-Gutierrez R, Garcia-Leal M, Raygoza-Cortez K, Flores-Rodríguez A, Moreno-Alvarado M, Heredia-Martínez EM, et al. Benefits and harms of fibrate therapy in patients with type 2 diabetes: a systematic review and meta-analysis. Endocrine. 2023;81(2):231–45.

Article  CAS  PubMed  Google Scholar 

Goldberg RB. Dyslipidemia in diabetes: when and how to treat? Endocrinol Metab Clin North Am. 2022;51(3):603–24.

Article  PubMed  Google Scholar 

Appelman Y, van Rijn BB, ten Haaf ME, Boersma E, Peters SAE. Sex differences in cardiovascular risk factors and disease prevention. Atherosclerosis. 2015;241(1):211–8.

Article  CAS  PubMed  Google Scholar 

Peters SA, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia. 2014;57(8):1542–51.

Article  PubMed  Google Scholar 

Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet (London England). 2014;383(9933):1973–80.

Article  PubMed  Google Scholar 

Peters SAE, Woodward M. Sex differences in the burden and complications of diabetes. Curr Diab Rep. 2018;18(6):33.

Article  PubMed  PubMed Central  Google Scholar 

Shamshirgaran SM, Mamaghanian A, Aliasgarzadeh A, Aiminisani N, Iranparvar-Alamdari M, Ataie J. Age differences in diabetes-related complications and glycemic control. BMC Endocr Disord. 2017;17(1):25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Das S, Haroled Peter PL, Bhavani ML, Naresh P, Ramana MV. Age- and sex-related prevalence and drug utilization pattern in the management of type 2 diabetes mellitus and its comorbidity with cardiovascular diseases: a comparative study. Indian J Pharm Sci. 2015;77(4):478–84.

Article  CAS  PubMed  PubMed Central  Google Scholar